| NCT ID | NCT03450005 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Cologne |
| Condition | Invasive Candidiases |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2018-01-18 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2018-01-18 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of the European Confederation of Medical Mycology - ECMM Candida Registry (CandiReg) is to overcome the lack of knowledge on epidemiology, clinical course, and molecular characteristics of invasive infections due to invasive Candida infections and to function as a platform for future studies and in case of outbreaks.
Eligibility Criteria
Inclusion Criteria: * Cultural, histopathological, antigen or DNA evidence of invasive fungal infection with Candida species. * Hepatosplenic candidiasis with signs of disseminated Candida infection without culture, histological or microscopic evidence * Case control Matching procedure for controls: In part, controls will be included at the same hospitals that include cases (i.e. each one control per case, both in the same hospital). Controls will be matched by demographics, underlying diseases and risk factors as well as duration of hospitalization Exclusion Criteria: \- Colonization or other non-invasive infection, including superficial skin infections, candiduria without dissemination or Candida spp. in stool.
Contact & Investigator
Oliver Cornely, MD
STUDY CHAIR
University of Cologne
Frequently Asked Questions
Who can join the NCT03450005 clinical trial?
This trial is open to participants of all sexes, studying Invasive Candidiases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03450005 currently recruiting?
Yes, NCT03450005 is actively recruiting participants. Contact the research team at oliver.cornely@uk-koeln.de for enrollment information.
Where is the NCT03450005 trial being conducted?
This trial is being conducted at Cologne, Germany.
Who is sponsoring the NCT03450005 clinical trial?
NCT03450005 is sponsored by University of Cologne. The principal investigator is Oliver Cornely, MD at University of Cologne. The trial plans to enroll 2,000 participants.